Racial, ethnic, and socioeconomic disparities in rates of stage IV prostate cancer after USPSTF category "D" recommendation against prostate-specific antigen screening: a retrospective cohort study

被引:0
|
作者
Thakker, Parth U. [1 ]
Perry, Alan G. [2 ]
Hemal, Ashok K. [1 ]
Bercu, Caleb H. [1 ,2 ]
Petrou, Steven P. [2 ]
Pak, Raymond W. [2 ]
Broderick, Gregory A. [2 ]
Thiel, David D. [2 ]
Dora, Chandler D. [2 ]
Lyon, Timothy D. [2 ]
Igel, Todd C. [2 ]
Craven, Timothy E. [2 ]
Pathak, Ram A. [2 ]
机构
[1] Atrium Wake Forest Baptist Hlth, Dept Urol, Winston Salem, NC USA
[2] Mayo Clin, Dept Urol, 4500 San Pablo Rd S, Jacksonville, FL 32224 USA
关键词
African American; blood screening; Hispanics; prostate cancer (PCa); urology1103; MEN;
D O I
10.21037/tau-24-90
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Background: In 2012 the United States Preventative Services Task Force (USPSTF) changed its prostate-specific antigen (PSA) screening recommendation to a category "D". The purpose of this study is to examine racial, ethnic, and socioeconomic differences in risk of presentation with metastatic prostate cancer (mPCa) at time of diagnosis before and after the 2012 USPSTF category "D" recommendation. Methods: This is a population-based cohort study. We identified patients with mPCa at diagnosis within the National Cancer Database from 2004-2017. Logistic regression models were used to examine associations of mPCa with age, race, ethnicity, geographic location, education level, income, and insurance status. Linear regression models assuming underlying binomial distribution were fitted to annual percentage of mPCa at diagnosis for years 2012-2017 to evaluate the post category "D" recommendation era. Results: From 2004 to 2017, 88,987 patients presented with mPCa. A higher percentage of mPCa was noted post-USPSTF category "D" recommendation, with a disproportionately greater increase observed among Hispanics and non-Hispanic Blacks [Delta slope/year: Hispanics (0.0092), non-Hispanic Blacks (0.0073) and non-Hispanic Whites (0.0070)]. Insurance status impacts race/ethnicity differently: uninsured Hispanics were 3.66 times more likely to present with mPCa than insured Hispanics, while uninsured non-Hispanic Blacks were 2.62 times more likely to present with mPCa than insured non-Hispanic Blacks. Household income appears to be associated with differences in mPCa, particularly among non-Hispanic Blacks. Those earning <$30,000 were more likely to present with mPCa compared to higher income brackets. Conclusions: Since the USPSTF grade "D" recommendation against PSA screening, the percentage of mPCa at diagnosis has increased, with a higher rate of increase among Hispanic and non-Hispanic Blacks compared to non-Hispanic Whites.
引用
收藏
页码:1092 / 1103
页数:12
相关论文
共 50 条
  • [1] Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer-Specific Mortality
    Burgess, Laura
    Aldrighetti, Christopher M.
    Ghosh, Anushka
    Niemierko, Andrzej
    Chino, Fumiko
    Huynh, Melissa J.
    Efstathiou, Jason A.
    Kamran, Sophia C.
    JAMA NETWORK OPEN, 2022, 5 (05)
  • [2] Racial or Ethnic and Socioeconomic Disparities in Prostate Cancer Survivors' Prostate-specific Quality of Life
    Orom, Heather
    Biddle, Caitlin
    Underwood, Willie, III
    Homish, Gregory G.
    Olsson, Carl A.
    UROLOGY, 2018, 112 : 132 - 137
  • [3] Long-term consequences of the USPSTF Grade D recommendation for prostate-specific antigen screening
    Joshi, Shreyas S.
    Filson, Christopher P.
    CANCER, 2020, 126 (04) : 694 - 696
  • [4] Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012
    Butler, Santino S.
    Muralidhar, Vinayak
    Zhao, Shuang G.
    Sanford, Nina N.
    Franco, Idalid
    Fullerton, Zoe H.
    Chavez, Janice
    D'Amico, Anthony, V
    Feng, Felix Y.
    Rebbeck, Timothy R.
    Nguyen, Paul L.
    Mahal, Brandon A.
    CANCER, 2020, 126 (04) : 717 - 724
  • [5] Prostate cancer screening with Prostate-Specific Antigen (PSA) testing: A retrospective study
    Goktas, Olgun
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2024, 40 (10)
  • [6] Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States
    Mahal, B. A.
    Chen, Y. -W.
    Muralidhar, V.
    Mahal, A. R.
    Choueiri, T. K.
    Hoffman, K. E.
    Hu, J. C.
    Sweeney, C. J.
    Yu, J. B.
    Feng, F. Y.
    Kim, S. P.
    Beard, C. J.
    Martin, N. E.
    Trinh, Q. -D.
    Nguyen, P. L.
    ANNALS OF ONCOLOGY, 2017, 28 (05) : 1098 - 1104
  • [7] Racial and Ethnic Variation in Time to Prostate Biopsy After an Elevated Screening Level of Serum Prostate-specific Antigen
    Reading, Stephanie R.
    Porter, Kimberly R.
    Hsu, Jin-Wen Y.
    Wallner, Lauren P.
    Loo, Ronald K.
    Jacobsen, Steven J.
    UROLOGY, 2016, 96 : 121 - 127
  • [8] Utilization of Radical Prostatectomy Versus Radiation Therapy for Gleason Grade Group 5 Prostate Cancer Before and After USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening in 2012
    Mcginnis, H. Scott
    Corriher, Taylor
    Janopaul-Naylor, James
    Goyal, Subir
    Liu, Yuan
    Wang, Zelin
    Patel, Sagar A.
    CANCER MEDICINE, 2025, 14 (03):
  • [9] Changes in the outcome of prostate biopsies after preventive task force recommendation against prostate-specific antigen screening
    Zakaria, Ahmed S.
    Dragomir, Alice
    Brimo, Fadi
    Kassouf, Wassim
    Tanguay, Simon
    Aprikian, Armen
    BMC UROLOGY, 2018, 18
  • [10] Changes in the outcome of prostate biopsies after preventive task force recommendation against prostate-specific antigen screening
    Ahmed S. Zakaria
    Alice Dragomir
    Fadi Brimo
    Wassim Kassouf
    Simon Tanguay
    Armen Aprikian
    BMC Urology, 18